Navigation Links
China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results
Date:6/1/2011

60;(8)

0.090.350.44- diluted (8)

0.090.340.43Weighted average number of ADS- basic (8)

26,184,308-26,184,308- diluted (8)

26,448,663-26,448,663For the convenience of readers, certain RMB amounts have been translated into U.S. dollars at the rate of
RMB6.5483 to US$1.00, the noon buying rate in New York City for cable transfers of RMB per U.S. dollar as
set forth in the H.10 weekly statistical release of the Federal Reserve Board, as of Thursday, March 31, 2011.
No representation is made that the RMB amounts could have been or could be converted into U.S. dollars at
that rate or at any other rate on March 31, 2011 or at any other dates.Notes:For the Three Months EndedMarch 31, 2010March 31, 2011(1)
Net revenues

RMB'000RMB'000US$'000- Molecular diagnostic systems

100,897146,63522,393- Immunodiagnostic systems

74,83183,77912,794175,728230,41435,187Molecular diagnostic systems- HPV-DNA chips

-11,9221,821(2) Non-GAAP numbers exclude stock compensation expense and amortization of acquired intangible assets.For the Three Months EndedMarch 31, 2010March 31, 2011RMB'000RMB'000US$'000Stock compensation expense

-11017Amortization of acquired intangible assets22,42348,1857,35822,42348,2957,375(3) Non-GAAP numbers exclude stock compensation expense.(4) Non-GAAP numbers exclude amortization of acquired intangible assets.(5) Non-GAAP numbers exclude non-cash interest expense of convertible
'/>"/>

SOURCE China Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Research and Markets ... Instrument Industry Report, 2014-2017" report to their offering. ... rising proportion of reimbursement for medical expenses, the Chinese ... its scale presenting a CAGR of 19.2% during 2009-2013. ... product segments of orthopedic instruments in China ...
(Date:8/29/2014)... , August 29, 2014 ... Oil Market by Extraction type (SFE, Cold Pressed, ... Personal Care, Pharmaceutical, Food Supplements, Fragrance, & Others) - ... MarketsandMarkets, defines and segments the Amaranth Seed Oil ... market size in terms of value. The Amaranth ...
(Date:8/29/2014)... , Aug. 29, 2014  United Therapeutics Corporation ... U.S. District Court for the District of ... in the company,s case against Sandoz, Inc. regarding United ... Peter Sheridan ruled that U.S. Patent No. 6,765,117 ... enjoined Sandoz from marketing its generic product until the ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4District Court Decision Received In Remodulin Patent Case 2
... , MONMOUTH JUNCTION, N.J., Oct. 19 Transave Inc., ... lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation), an ... The latest results along with previously reported data demonstrate ... program in two indications - for the treatment of ...
... WORTH, Texas, Oct. 19 Galderma Laboratories proudly announces ... Cetaphil® UVA/UVB Defense SPF 50 have recently been granted ... Good Housekeeping Research Institute. , The Good Housekeeping Seal ... "tested and approved" emblems in the U.S. , "It ...
Cached Medicine Technology:Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections 2Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections 3Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections 4Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections 5Three Cetaphil(R) Products Earn Good Housekeeping Seal 2
(Date:8/30/2014)... The SI Joint Evaluation and Treatment covers ... energy techniques. Michael P. Reiman PT, DPT, OCS, SCS, ... for the SI Joint. This PT online ... presentation with North American Seminars. , PT ... differential diagnosis approach to a thorough examination of the ...
(Date:8/30/2014)... What challenges exist in recruiting top talent ... concerns, and considerations? Sports Conflict Institute ’s ... with Woody Wommack, Southeast Football Recruiting Analyst of Rivals.com/Yahoo! ... recruiting. Notably, Wommack spoke on what the recruiting ... thinks are coming as a result of the O’Bannon ...
(Date:8/30/2014)... 30 August 2014: A new sudden death predictor ... for implantable cardioverter defibrillators (ICDs) in ESC Guidelines ... by Task Force Chairperson Professor Perry Elliott (UK). ... Management of Hypertrophic Cardiomyopathy" are published today on-line ... and on the ESC Website. Previous ESC Guidelines ...
(Date:8/29/2014)... Cancer is a life-changing illness that ... Eddie M. Leung knows the suffering that patients go through; ... cancer, a very rare and aggressive form of cancer. In ... by Xlibris), he shares a glimpse into his struggles as ... testimony that this disease can be overcome. , ...
(Date:8/29/2014)... Denver, Colorado (PRWEB) August 29, 2014 Daily Gossip ... the program was created by a former cold sores patient who ... this method is Ellie Gadsby, who decided to share her tips ... the world. , The author of the Get Rid of ... sores for 22 years, while in the least 4 years outbreaks ...
Breaking Medicine News(10 mins):Health News:North American Seminars Online PT Continuing Education Course, Examination and Treatment of the SI Joint, Receives Continuing Education Approval in NJ, CA, IL, PA, & TX 2Health News:Woody Wommack of Rivals.com Discusses the World of NCAA Football Recruiting on SCI TV 2Health News:Woody Wommack of Rivals.com Discusses the World of NCAA Football Recruiting on SCI TV 3Health News:Sudden death predictor identifies ICD candidates in new ESC Guidelines 2Health News:Eddie M. Leung Shares His Testimony As a Survivor of Cancer 2Health News:Eddie M. Leung Shares His Testimony As a Survivor of Cancer 3Health News:Get Rid of Cold Sores Fast Review Reveals Simple Way to Eliminate Cold Sores in 12 Hours 2
... Hill-Rom Holdings, Inc. (NYSE: HRC ) today ... share. This dividend was declared by Hill-Rom,s Board of Directors ... 2009 to shareholders of record as of March 17, 2009. ... is a leading worldwide manufacturer and provider of medical technologies ...
... potential partners is easier to read than women,s, speed-dating study ... unattached this Valentine,s Day and you,re hoping to change that, ... easier to judge how interested a man is than it ... , Men who are attracted to women, it seems, are ...
... SYDNEY, Feb. 13 /PRNewswire-,FirstCall/ -- Thoratec Corporation ... leader in device-,based mechanical circulatory support therapies ... HeartWare International (ASX: HIN), which develops and,manufactures ... they,have entered into a definitive merger agreement ...
... through. , ... (Vocus) February 13, 2009 -- For centuries Mardi Gras - also known ... last bits of fat and meat in millions of homes in preparation for ... favorite foods. Meat is often chosen for this observance, as indicated by ...
... The Ensign Group, Inc. (Nasdaq: ... group of skilled nursing, rehabilitative care services and ... to issue its fourth quarter and fiscal year ... Wednesday, February 18, 2009.(Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) ...
... also affect chances of having debilitating headaches , , THURSDAY, Feb. ... of migraine headaches in young and middle-aged adults, suggests a ... and the way body fat was distributed affected migraine risk. ... more likely to have migraines than those with smaller waistlines. ...
Cached Medicine News:Health News:Men, the Obvious Sex 2Health News:Men, the Obvious Sex 3Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 2Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 3Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 4Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 5Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 6Health News:Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million; 7Health News:Mardi Gras Gives Everyone a Big Fat Break Because Carnival Means "So Long" to Meat 2Health News:Mardi Gras Gives Everyone a Big Fat Break Because Carnival Means "So Long" to Meat 3Health News:The Ensign Group Schedules 2008 Year End Earnings Call for Thursday, February 19, 2009 2Health News:Belly Fat May Make Migraines More Likely 2
... a combination of innovative design, consistently reliable ... I-125 implant an ideal choice for your ... every BrachySource I-125 implant order is backed ... required by clinicians who must meet the ...
... BrachySource iodine-125 implant is a combination of ... visibility that makes BrachySource I-125 implant an ... can be confident that every BrachySource I-125 ... management services which is required by clinicians ...
The silicone Tractfinder provides excellent fluoroscopic visualization. Manipulation of the movable core guidewire flexes the tapered proximal tip for maximum control in negotiating a tortuous ureter...
... Used for temporary internal drainage from the ... of a stricture. The segment with no ... lumen while preventing ingrowth of the ureteral ... peel-open packages. Intended for one-time use. CAUTION: ...
Medicine Products: